Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Expansion of a unique CD57+NKG2Chinatural killer cell subset during acute human cytomegalovirus infectionProceedings of the National Academy of Sciences of the United States of America, 2011
- Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytesProceedings of the National Academy of Sciences, 2010
- Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor modelInternational Journal of Cancer, 2010
- Herpes simplex type I (HSV-1) infection of the nervous system: Is an immune response a good thing?Journal of Neuroimmunology, 2010
- Secretion of interferon‐γ by human macrophages demonstrated at the single‐cell level after costimulation with interleukin (IL)‐12 plus IL‐18Immunology, 2009
- Adaptive immune features of natural killer cellsNature, 2009
- Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infectionProceedings of the National Academy of Sciences, 2008
- The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitisJournal of Neurochemistry, 2008
- The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitisExperimental Neurology, 2007